Introduction: The Models of Patient Engagement for Alzheimer's Disease (MOPEAD) project was conceived to explore innovative complementary strategies to uncover hidden prodromal and mild Alzheimer's disease (AD) dementia cases and to raise awareness both in the general public and among health professionals about the importance of early diagnosis. Methods: Four different strategies or RUNs were used: (a) a web-based (WB) prescreening tool, (2) an open house initiative (OHI), (3) a primary care–based protocol for early detection of cognitive decline (PC), and (4) a tertiary care–based pre-screening at diabetologist clinics (DC). Results: A total of 1129 patients at high risk of having prodromal AD or dementia were identified of 2847 pre-screen...
Objectives: Recent evidence suggests that a substantial minority of people clinically diagnosed with...
<p><strong>PROJECT SUMMARY</strong>:<br>Pathophysiological processes that lead to Alzheimer’s diseas...
Background: There is an urgent need to identify subjects with Alzheimer's disease (AD) in the predem...
Introduction: The Models of Patient Engagement for Alzheimer's Disease (MOPEAD) project was conceive...
Introduction The Models of Patient Engagement for Alzheimer's Disease (MOPEAD) project was conceived...
Introduction: Innovative patient engagement models are required to identify people with prodromal an...
In most, if not all health systems, dementia is underdiagnosed, and when diagnosis occurs, it is typ...
In most, if not all health systems, dementia is underdiagnosed, and when diagnosis occurs, it is typ...
Background: For care planning and support, under-detection and late diagnosis of Alzheimer's disease...
Introduction: Alzheimer’s Disease (AD) is a progressive neurodegenerative condition in which individ...
Alzheimer's disease (AD) is a progressive neurodegenerative disorder that is the most common cause o...
Item does not contain fulltextBACKGROUND: There is an urgent need to identify subjects with Alzheime...
Alzheimer's disease (AD) is the most common cause of dementia affecting 36 million people worldwide....
BACKGROUND: Definitions and diagnostic criteria for all medical conditions are regularly subjected t...
Alzheimer’s disease (AD) is a major cause of the rapidly growing and crushing aging challenge that t...
Objectives: Recent evidence suggests that a substantial minority of people clinically diagnosed with...
<p><strong>PROJECT SUMMARY</strong>:<br>Pathophysiological processes that lead to Alzheimer’s diseas...
Background: There is an urgent need to identify subjects with Alzheimer's disease (AD) in the predem...
Introduction: The Models of Patient Engagement for Alzheimer's Disease (MOPEAD) project was conceive...
Introduction The Models of Patient Engagement for Alzheimer's Disease (MOPEAD) project was conceived...
Introduction: Innovative patient engagement models are required to identify people with prodromal an...
In most, if not all health systems, dementia is underdiagnosed, and when diagnosis occurs, it is typ...
In most, if not all health systems, dementia is underdiagnosed, and when diagnosis occurs, it is typ...
Background: For care planning and support, under-detection and late diagnosis of Alzheimer's disease...
Introduction: Alzheimer’s Disease (AD) is a progressive neurodegenerative condition in which individ...
Alzheimer's disease (AD) is a progressive neurodegenerative disorder that is the most common cause o...
Item does not contain fulltextBACKGROUND: There is an urgent need to identify subjects with Alzheime...
Alzheimer's disease (AD) is the most common cause of dementia affecting 36 million people worldwide....
BACKGROUND: Definitions and diagnostic criteria for all medical conditions are regularly subjected t...
Alzheimer’s disease (AD) is a major cause of the rapidly growing and crushing aging challenge that t...
Objectives: Recent evidence suggests that a substantial minority of people clinically diagnosed with...
<p><strong>PROJECT SUMMARY</strong>:<br>Pathophysiological processes that lead to Alzheimer’s diseas...
Background: There is an urgent need to identify subjects with Alzheimer's disease (AD) in the predem...